HAYDEE BIRKHIMER: Open Payments
NPI 1497046791 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 71 payments from 13 companies in 2025. Trend: 2023 $1,111 · 2024 $4,870 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $247 |
| ABBVIE INC. | 12 | $180 |
| Lilly USA, LLC | 14 | $168 |
| Amgen Inc. | 13 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| PFIZER INC. | 4 | $66 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| GENZYME CORPORATION | 1 | $28 |
Products named: MOUNJARO, Ozempic, OTEZLA, JARDIANCE, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY, VRAYLAR.
Industry payments across TX — which companies pay providers there.
